Registered entities
MINDIMMUNE THERAPEUTICS, INC.
Reg. No. 81-2613707United States
Innovation
3 patent families (2 granted) — focus: Human necessities, Physics & computing; filing pace slowing. Cited 202 times.
| Year | Filings |
|---|---|
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 1 |
Social engagement
Social engagement: 1.8K social following, 9 posts in the last 12 months — below the industry typical range.
Investor mix
8 investors on record; lead investors include Slater Technology Fund, Dolby Family Ventures, Alzheimer's Drug Discovery, Trend-venture.com.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 50% |
| Other / undisclosed | 4 | 50% |
Recent activity
1 Jul 2026
Event
Alzheimers Association International Conference (AAIC) 2026
24 Jun 2026
Event
BIO International Convention 2026
17 Jun 2026
Event
BIO 2026